SBIR-STTR Award

Open Call for Science and Technology Created by Early-Stage (e.g. University) Teams
Award last edited on: 9/20/21

Sponsored Program
STTR
Awarding Agency
DOD : AF
Total Award Amount
$25,000
Award Phase
1
Solicitation Topic Code
AF19C-T010
Principal Investigator
David K Mills

Company Information

Nano Medicine Research & Development LLC

201 Mayfield Avenue
Monroe, LA 71270
   (318) 267-5644
   info@nanomedla.com
   www.nanomedla.com

Research Institution

Louisiana Tech University

Phase I

Contract Number: FA8649-20-P-0390
Start Date: 12/12/19    Completed: 12/12/20
Phase I year
2020
Phase I Amount
$25,000
Vehicular accidents, battlefield engagements and mass disasters natural and human-made are critical events where speed and ease of use in stabilizing the injured for subsequent evacuation is a critical need.Failure to halt bleeding in the critically injured can result in death before their evacuation to hospitals or other permanent treatment facilities or can result in more extended convalescence periods increasingmedical costs for families, hospitals, and insurers. E�cient hemostasis is beneficial for both damage control and tissue repair after injury, e.g., trauma or surgery, which can significantly decrease the mortality rate.Our multi-functional bandage is a natural nanocomposite created from FDA approved polymers (chitosan, PCL, PLA) containing drug-doped HNTs and mHNTs. The doped HNTs can deliver a broad suite ofbioactive molecules, including antibiotics, contrast agents, coagulants, disinfectants, cancer drugs, and growth factors. It is designed to be an active, hemostatic agent designed to help control bleeding from openwounds and in body cavities (mouth, ears, nose, throat, vagina, and anus). The material contains no chemical additives, is not immunogenic, and is hypoallergenic. When it comes in contact with blood, anti-clotting factors are released immediately followed by time-release delivery of anti-bacterial and wound healing promoting agent

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----